BKM120 sensitizes glioblastoma to the PARP inhibitor rucaparib by suppressing homologous recombination repair.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/CD4CD4F2.svg?ark=w1%2F20260526%2FCD4CD4F2)](https://nobleid.org/work/w1/20260526/CD4CD4F2)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors